Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers in-patient, daycase, and out-patient care services through hospitals and clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Spire Healthcare Group Plc

Mr. Justinian Joseph Ash BA (Hons)

CEO & Executive Director

Mr. Harbant Singh Samra

CFO & Director

Mr. John  Forrest

Chief Operating Officer

Mr. Angus  Prentice

Interim Head of Investor Relations

Mr. Mantraraj Dipak Budhdev

Group General Counsel, Company Secretary & Corporate Concerns Director

Ms. Rachel  King

Group People Director

Mr. Peter  Corfield

Chief Commercial Officer

Prof. Lisa Jane Grant

Group Clinical Director & Chief Nurse

Mr. Derrick  Farrell

CEO of Vita Health Group

Dr. Cathy  Cale

Group Medical Director

Spire Healthcare Group Plc (SPI) Stock Analysis, Discussion Forum and Financial Metrics - LSE Exchange

SPI's latest dividend is 0.021 GBP on May 23, 2024

SPI Stock Discussion Forum and Message Board

News for LSE: SPI